Lonza Group AG (FRA:LO3)

Germany flag Germany · Delayed Price · Currency is EUR
600.00
+10.80 (1.83%)
At close: Oct 20, 2025
1.83%
Market Cap42.50B
Revenue (ttm)7.59B
Net Income (ttm)784.82M
Shares Outn/a
EPS (ttm)11.10
PE Ratio54.15
Forward PE30.45
Dividend4.27 (0.73%)
Ex-Dividend DateMay 13, 2025
Volume54
Average Volume11
Open605.00
Previous Close589.20
Day's Range600.00 - 605.20
52-Week Range555.80 - 639.20
Betan/a
RSI57.27
Earnings DateOct 28, 2025

About Lonza Group AG

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substanc... [Read more]

Industry Chemicals and Allied Products
Founded 1897
Employees 18,944
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol LO3
Full Company Profile

Financial Performance

In 2024, Lonza Group AG's revenue was 6.57 billion, a decrease of -2.13% compared to the previous year's 6.72 billion. Earnings were 636.00 million, a decrease of -2.75%.

Financial numbers in CHF Financial Statements

News

There is no news available yet.